Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. (cancernetwork.com)
He was instrumental in the clinical development leading to the approval of ipilimumab for advanced melanoma, and recently designed and led a global phase 3 trial of combined checkpoint blockade for melanoma. (sciencemag.org)
A study of six people with these variations, out of 79 patients who were previously treated with ipilimumab for metastatic melanoma, found a higher likelihood of progression - free survival. (sciencedaily.com)